1
|
Ghader N, AlMheiri N, Fikri A, AbdulRazzak H, Saleheen H, Saddik B, Aljawarneh Y, Dalky H, Al Banna A, Al Memari S, Al Shehhi B, Al Mazrouei S, Al Hajeri O. Prevalence and factors associated with mental illness symptoms among school students post lockdown of the COVID-19 pandemic in the United Arab Emirates: A cross-sectional national study. PLoS One 2024; 19:e0296479. [PMID: 38300941 PMCID: PMC10833540 DOI: 10.1371/journal.pone.0296479] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/12/2022] [Accepted: 12/12/2023] [Indexed: 02/03/2024] Open
Abstract
Limited data exists on the mental health of children in the United Arab Emirates (UAE). This study aimed to fill this gap by examining the prevalence of anxiety, depression, and risk for Post-Traumatic Stress Disorder (PTSD) among school students in post-lockdown of the COVID-19 pandemic. A sample of 3,745 school students participated, responding to standardized tests (Mood and Feeling Questionnaire-Child Self-Report, Screen for Child Anxiety Related Disorders-Child Version, and Children's Revised Impact of Event Scale-8). Findings showed that the risk for PTSD was the most prevalent (40.6%), followed by symptoms of anxiety (23.3%), and depression (17.1%). For gender differences, symptoms of the three conditions (depression, anxiety, and PTSD) were higher in female students (9.2%) compared to male peers (7.7%) (p = 0.09). Moreover, symptoms of depression and anxiety were found to be higher among late adolescents (p<0.05). Further analysis revealed that having medical problems was a positive predictor for anxiety (OR = 2.0, p<0.01) and risk for PTSD (OR = 1.3, p = 0.002); similarly, witnessing the death of a close family member due to COVID-19 (OR for depression, anxiety, and PTSD = 1.7, p<0.01) were positive predictors associated with PTDS, depression, and anxiety. The study concluded that post COVID-19 lockdown, symptoms of anxiety, depression, and risk for PTSD were found to be prevalent among school students in the UAE. Researchers put forward recommendations on the initiation of a national school mental health screening program, the provision of follow-up services for vulnerable students, and the integration of a mental health support system in the disaster preparedness plans.
Collapse
Affiliation(s)
- Nariman Ghader
- Mental Health Department, Emirates Health Services, Dubai, United Arab Emirates
| | - Noor AlMheiri
- Mental Health Department, Emirates Health Services, Dubai, United Arab Emirates
| | - Asma Fikri
- National Center for Health Research, Ministry of Health and Prevention, Dubai, United Arab Emirates
| | - Hira AbdulRazzak
- Statistics and Research Center, Ministry of Health and Prevention, Dubai, United Arab Emirates
| | - Hassan Saleheen
- Abu Dhabi Public Health Center, Department of Health, Abu Dhabi, United Arab Emirates
| | - Basema Saddik
- Department of Family and Community Medicine, University of Sharjah, Sharjah, United Arab Emirates
| | - Yousef Aljawarneh
- Faculty of Health Sciences, Higher Colleges of Technology, Dubai, United Arab Emirates
| | - Heyam Dalky
- Faculty of Health Sciences, Higher Colleges of Technology, Dubai, United Arab Emirates
| | - Ammar Al Banna
- Child and Adolescent Mental Health Center of Excellence, Al Jalila Children’s Specialty Hospital, Dubai, United Arab Emirates
| | - Shammah Al Memari
- Statistics and Research Center, Ministry of Health and Prevention, Dubai, United Arab Emirates
| | - Budoor Al Shehhi
- Statistics and Research Center, Ministry of Health and Prevention, Dubai, United Arab Emirates
| | - Shereena Al Mazrouei
- Statistics and Research Center, Ministry of Health and Prevention, Dubai, United Arab Emirates
| | - Omniyat Al Hajeri
- Statistics and Research Center, Ministry of Health and Prevention, Dubai, United Arab Emirates
| |
Collapse
|
2
|
AlKetbi LMB, Al Hosani F, Al Memari S, Al Mazrouei S, Al Shehhi B, AlShamsi N, AlKwuiti MM, Saleheen HN, Al Mutairi H, Al Hajeri OM. Parents' views on the acceptability of a COVID-19 vaccine for their children: A cross-sectional study in Abu Dhabi-United Arab Emirates. Vaccine 2022; 40:5562-5568. [PMID: 35987873 PMCID: PMC9376339 DOI: 10.1016/j.vaccine.2022.07.056] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2021] [Revised: 07/25/2022] [Accepted: 07/26/2022] [Indexed: 11/17/2022]
Abstract
BACKGROUND The United Arab Emirates had approved the COVID-19 vaccine for children. Assessing parents' acceptance of the vaccine for their children will influence decision-making in the COVID-19 vaccine roll-out. METHOD Parents registered inthe AbuDhabiDepartmentofEducation (12,000 families) were invitedtocompleteanonlinequestionnaire from 8th September 2021 to 17th October 2021. Out of the 12,000 families, 2510 (21%) participants answered the survey. The questionnaire investigated the parents' attitudes and beliefs regarding the COVID-19 vaccine. RESULTS The vaccination rate among this group of respondents was high, with 2255 (89.9%) having received two doses and 1002 (45.5%) having already received a booster dose. Acceptance of the respondents to vaccinate their children was high, (75.1%) said they would vaccinate their children, with 64.4% reporting that they would immediately vaccinate their children if the vaccine were made available. Determinants of COVID-19 child vaccination acceptance included the respondent's vaccination status-i.e., if the respondent is already vaccinated (OR 4.96 [2.89-8.53]) or has taken the third dose (OR 2.37 [1.4-4.01])-their children's age (OR 1.11 [1.30-1.18] for older children), and their trust in the following information sources: the government (OR 2.53 [1.61-3.98]), health care providers (OR 1.98 [1.2-3.24]), or social media (OR 2.17 [1.22-3.88]). Increased level of education had a negative impact on the acceptance of giving the vaccine to children (OR 0.63 [0.52-0.77]); fear of side effects OR 0.000164 (0.000039-0.001) was another determinant. The main factor that encouraged parents to give their children the vaccine was to protect their child's health as reported by 1537 (55.5%) participants. CONCLUSION The Abu Dhabi community is highly accepting of the vaccine for their children. Future studies of how this vaccine acceptance can influence the pandemic are needed.
Collapse
Affiliation(s)
| | - Farida Al Hosani
- Abu Dhabi Public Health Center, Communicable Disease Sector, Abu Dhabi, United Arab Emirates.
| | - Shammah Al Memari
- Abu Dhabi Public Health Center, Health Promotion Department, Abu Dhabi, United Arab Emirates.
| | - Shereena Al Mazrouei
- Abu Dhabi Public Health Center, Communicable Disease Sector, Abu Dhabi, United Arab Emirates.
| | - Badreyya Al Shehhi
- Abu Dhabi Public Health Center, Communicable Disease Sector, Abu Dhabi, United Arab Emirates.
| | - Noura AlShamsi
- Academic Affairs Department, Ambulatory Healthcare Services, Abu Dhabi Healthcare Services, Al Ain, United Arab Emirates.
| | - Mariam M AlKwuiti
- Academic Affairs Department, Ambulatory Healthcare Services, Abu Dhabi Healthcare Services, Al Ain, United Arab Emirates.
| | - Hassan Nazmus Saleheen
- Abu Dhabi Public Health Center, Communicable Disease Sector, Abu Dhabi, United Arab Emirates.
| | - Hanan Al Mutairi
- Abu Dhabi Public Health Center, Communicable Disease Sector, Abu Dhabi, United Arab Emirates.
| | | |
Collapse
|
3
|
AlKetbi LMB, Elharake JA, Memari SA, Mazrouei SA, Shehhi BA, Malik AA, McFadden SM, Galal B, Yildirim I, Khoshnood K, Omer SB, Memish ZA, AlZarouni AA, AlNeyadi AM, Hosani FA. COVID-19 vaccine acceptance among healthcare workers in the United Arab Emirates. IJID Reg 2021; 1:20-26. [PMID: 35721775 PMCID: PMC8505903 DOI: 10.1016/j.ijregi.2021.08.003] [Citation(s) in RCA: 13] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 07/28/2021] [Revised: 08/25/2021] [Accepted: 08/26/2021] [Indexed: 12/13/2022]
Abstract
Background COVID-19 vaccine hesitancy among healthcare workers (HCWs) is a threat to any healthcare system. Vaccine hesitancy can increase infection risk among HCWs and patients, while also impacting the patients' decision to accept the vaccine. Our study assessed COVID-19 vaccine acceptance among HCWs in United Arab Emirates (UAE). Methods Using purposive sampling, UAE HCWs registered in the Abu Dhabi Department of Health (DOH) email database were invited to complete an online questionnaire, between November 2020 and February 2021, to understand COVID-19 vaccine acceptance and hesitancy, and trust in sources of information. Simple logistic regression was used to assess the associations between demographic factors with COVID-19 vaccine acceptance. Results Of the 2832 HCWs who participated in the study, 1963 (69.9%) were aged between 25 and 44 years and 1748 (61.7%) were females. Overall, 2525 (89.2%) of the HCW population said they would accept a COVID-19 vaccine. HCWs who were 55+ years of age, male, and physicians/surgeons were more likely to accept a COVID-19 vaccine (OR 3.1, 95% CI 1.5-6.2, p = 0.002; OR 1.8, 95% CI 1.3-2.4, p < 0.001; and OR 1.8, 95% CI 1.1-2.9; p = 0.01, respectively). The most reliable sources for COVID-19 vaccine information were the UAE government (91.6%), healthcare providers (86.8%), health officials (86.3%), and the World Health Organization (WHO; 81.1%). Conclusions COVID-19 vaccine acceptance was high among the UAE HCW population. Several factors were identified as significant determinants of vaccine acceptance. UAE healthcare authorities can utilize these findings to develop public health messaging campaigns for HCWs to best address COVID-19 vaccine concerns - particularly when the government is vaccinating its general population.
Collapse
Affiliation(s)
| | - Jad A Elharake
- Yale Institute for Global Health, New Haven, Connecticut 06510, USA.,Department of Internal Medicine, Infectious Disease, Yale School of Medicine, New Haven, Connecticut, 06510, USA
| | - Shammah Al Memari
- Abu Dhabi Public Health Center, Health Promotion Department, Abu Dhabi, UAE
| | | | - Badreyya Al Shehhi
- Abu Dhabi Public Health Center, Communicable Disease Sector, Abu Dhabi, UAE
| | - Amyn A Malik
- Yale Institute for Global Health, New Haven, Connecticut 06510, USA.,Department of Internal Medicine, Infectious Disease, Yale School of Medicine, New Haven, Connecticut, 06510, USA
| | - SarahAnn M McFadden
- Yale Institute for Global Health, New Haven, Connecticut 06510, USA.,Department of Internal Medicine, Infectious Disease, Yale School of Medicine, New Haven, Connecticut, 06510, USA
| | - Bayan Galal
- Yale University, New Haven, Connecticut, 06520, USA
| | - Inci Yildirim
- Yale Institute for Global Health, New Haven, Connecticut 06510, USA.,Department of Internal Medicine, Infectious Disease, Yale School of Medicine, New Haven, Connecticut, 06510, USA
| | - Kaveh Khoshnood
- Yale School of Public Health, New Haven, Connecticut, 06510, USA
| | - Saad B Omer
- Yale Institute for Global Health, New Haven, Connecticut 06510, USA.,Department of Internal Medicine, Infectious Disease, Yale School of Medicine, New Haven, Connecticut, 06510, USA.,Yale School of Public Health, New Haven, Connecticut, 06510, USA.,Yale School of Nursing, Orange, Connecticut, 06477, USA
| | - Ziad A Memish
- Research and Innovation Center, King Saud Medical City, Ministry of Health, the Kingdom of Saudi Arabia.,College of Medicine, Alfaisal University, Riyadh, the Kingdom of Saudi Arabia.,Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA
| | - Amal A AlZarouni
- Academic Affairs Department, Ambulatory Healthcare Services, Abu Dhabi Healthcare Services, Al Ain, UAE
| | - Amna M AlNeyadi
- Academic Affairs Department, Ambulatory Healthcare Services, Abu Dhabi Healthcare Services, Al Ain, UAE
| | - Farida Al Hosani
- Abu Dhabi Public Health Center, Communicable Disease Sector, Abu Dhabi, UAE
| |
Collapse
|
4
|
Alsuwaidi AR, Al Hosani FI, Al Memari S, Narchi H, Abdel Wareth L, Kamal H, Al Ketbi M, Al Baloushi D, Elfateh A, Khudair A, Al Mazrouei S, AlHumaidan HS, Alghaithi N, Afsh K, Al Kaabi N, Altrabulsi B, Jones M, Shaban S, Sheek-Hussein M, Zoubeidi T. Seroprevalence of COVID-19 infection in the Emirate of Abu Dhabi, United Arab Emirates: a population-based cross-sectional study. Int J Epidemiol 2021; 50:1077-1090. [PMID: 33893483 PMCID: PMC8135550 DOI: 10.1093/ije/dyab077] [Citation(s) in RCA: 11] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 03/23/2021] [Indexed: 01/08/2023] Open
Abstract
Background The United Arab Emirates (UAE) was the first country in the Middle East to report severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Serosurveys are essential to understanding the extent of virus transmission. This cross-sectional study aims to assess the seroprevalence of SARS-CoV-2 infection in the Emirate of Abu Dhabi. Methods Between 19 July and 14 August 2020, 4487 households were selected using a random sample stratified by region and citizenship of the head of household (UAE citizen or non-citizen). A cluster sample of 40 labour camps was selected. Data on socio-demographic characteristics, risk factors and symptoms compatible with coronavirus disease 2019 (COVID-19) were collected. Each participant was first tested by Roche Elecsys® Anti-SARS-CoV-2 assay, followed, when reactive, by the LIAISON® SARS-CoV-2 S1/S2 IgG assay. Results Among 8831 individuals from households, seroprevalence was 10·4% [95% confidence intervals (CIs) 9·5–11·4], with higher seroprevalence in Abu Dhabi and Al Ain regions compared with those in Al Dhafra. In households, we found no sex difference and UAE citizens had lower seroprevalence compared with those of other nationalities. Among 4855 workers residing in labour camps, seroprevalence was 68·6% (95% CI 61·7–74·7), with higher seroprevalence among workers from Southeast Asia. In households, individuals with higher body mass indexes demonstrated higher seroprevalences than individuals with normal weight. Anosmia and ageusia were strongly associated with seropositivity. Conclusions The majority of household populations in the Emirate of Abu Dhabi remained unexposed to SARS-CoV-2. In labour camps, SARS-CoV-2 transmission was high. Effective public health measures should be maintained.
Collapse
Affiliation(s)
- Ahmed R Alsuwaidi
- Department of Pediatrics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates
| | | | | | - Hassib Narchi
- Department of Pediatrics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates
| | - Laila Abdel Wareth
- National Reference Laboratory, Abu Dhabi, United Arab Emirates.,Pathology & Laboratory Medicine Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates
| | - Hazem Kamal
- Abu Dhabi Public Health Center, Abu Dhabi, United Arab Emirates
| | - Mai Al Ketbi
- Ambulatory Healthcare Services, Abu Dhabi Health Services Company, Abu Dhabi, United Arab Emirates
| | - Durra Al Baloushi
- Ambulatory Healthcare Services, Abu Dhabi Health Services Company, Abu Dhabi, United Arab Emirates
| | - Abubaker Elfateh
- Sheikh Khalifa Medical City, Abu Dhabi Health Services Company, Abu Dhabi, United Arab Emirates
| | - Ahmed Khudair
- Abu Dhabi Public Health Center, Abu Dhabi, United Arab Emirates
| | | | - Hiba Saud AlHumaidan
- Sheikh Khalifa Medical City, Abu Dhabi Health Services Company, Abu Dhabi, United Arab Emirates
| | - Noura Alghaithi
- Ambulatory Healthcare Services, Abu Dhabi Health Services Company, Abu Dhabi, United Arab Emirates
| | - Khalil Afsh
- Al Dhafra Hospitals, Abu Dhabi Health Services Company, Abu Dhabi, United Arab Emirates
| | - Nawal Al Kaabi
- Sheikh Khalifa Medical City, Abu Dhabi Health Services Company, Abu Dhabi, United Arab Emirates
| | - Basel Altrabulsi
- National Reference Laboratory, Abu Dhabi, United Arab Emirates.,Pathology & Laboratory Medicine Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates
| | - Matthew Jones
- National Reference Laboratory, Abu Dhabi, United Arab Emirates
| | - Sami Shaban
- Department of Medical Education, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates
| | - Mohamud Sheek-Hussein
- Institute of Public Health, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates
| | - Taoufik Zoubeidi
- Department of Analytics in the Digital Era, College of Business and Economics, United Arab Emirates University, Al Ain, United Arab Emirates
| |
Collapse
|
5
|
Al Hosany F, Ganesan S, Al Memari S, Al Mazrouei S, Ahamed F, Koshy A, Zaher W. Response to COVID-19 pandemic in the UAE: A public health perspective. J Glob Health 2021; 11:03050. [PMID: 33828834 PMCID: PMC8005306 DOI: 10.7189/jogh.11.03050] [Citation(s) in RCA: 12] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
6
|
Hosani FA, Aden B, Memari SA, Mazrouei SA, Ajab S, Abid M, Alsuwaidi AR, Grivna M, Paulo MS, Sheek-Hussein M. Epidemiology of asymptomatic and symptomatic Coronavirus Disease 2019 confirmed cases in the Emirate of Abu Dhabi, United Arab Emirates: Observational study. Medicine (Baltimore) 2021; 100:e25219. [PMID: 33761710 PMCID: PMC9282025 DOI: 10.1097/md.0000000000025219] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/10/2020] [Revised: 02/14/2021] [Accepted: 02/22/2021] [Indexed: 01/05/2023] Open
Abstract
ABSTRACT This study was conducted to describe demographics, clinical features, and outcomes of 3827 confirmed cases of Coronavirus Disease 2019 between March 12 and April 22, 2020 in the Emirates of Abu Dhabi, United Arab Emirates (UAE).Data were extracted from the Infectious Diseases Notification Surveillance System of the Department of Health. The descriptive analysis was done using Statistical Package for Social Sciences v26 and reported according to Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement.We analyzed 3827 cases; 82% were men, 18% women, 14% UAE citizens, and 86% were of other nationalities. Most cases (72%) had lower exposure to low-risk occupations of infectious disease as per the classification of the department of health while high exposure risk occupations, which included healthcare worker accounts only for 3%. While 43% of cases were asymptomatic, 57% displayed symptoms, which were mostly mild. Only 12% of patients had comorbidities, which were significantly higher in men (9%) than women (3%). Among those who have comorbid conditions; hypertension (27%) and diabetes (21%) were the most common comorbidities. Viral pneumonia (11%) was the most common sequela documented in records. Only 51 patients (4%) required admission to the intensive care units, and 4 patients died (0.1%).The significant number of asymptomatic patients was identified by active case finding and contact tracing from the early period of the epidemic. A small percentage of severe, critical cases, and death reported in the Emirate of Abu Dhabi which may have been due to public health measures implemented for early detection, contact tracing, and treatment.
Collapse
Affiliation(s)
| | | | | | | | | | | | - Ahmed R. Alsuwaidi
- Department of Pediatrics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates
| | | | | | | |
Collapse
|